Back
CBRE Group, Inc. Vs. Regencell Bioscience Holdings Ltd. Industry Stock Comparison
Buy
73
CBRE
CBRE Group, Inc.
Last Price:
$165.95
Seasonality Move:
8.74%
Buy
70
RGC
Regencell Bioscience Holdings Ltd.
Last Price:
$41.51
Seasonality Move:
69.73%
Buy
73
CBRE Group, Inc. (CBRE)
is a Buy
Is CBRE Group, Inc. a Buy, Sell or Hold?
-
The current CBRE Group, Inc. [CBRE] share price is $166.33. The Score for CBRE is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
CBRE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
70
Regencell Bioscience Holdings Ltd. (RGC)
is a Buy
Is Regencell Bioscience Holdings Ltd. a Buy, Sell or Hold?
-
The current Regencell Bioscience Holdings Ltd. [RGC] share price is $52.88. The Score for RGC is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
RGC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CBRE Stock Price Chart
What is CBRE Group, Inc.'s stock price today?
-
The CBRE Group, Inc. share price today is $166.33Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CBRE is experiencing selling pressure, which indicates risk of future bearish movement.
RGC Stock Price Chart
What is Regencell Bioscience Holdings Ltd.'s stock price today?
-
The Regencell Bioscience Holdings Ltd. share price today is $52.88Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGC is experiencing buying pressure, which is a positive indicator for future bullish movement.
CBRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.87 | Buy |
| Relative Strength Index (14 RSI): | 62.01 | Buy |
| Chaikin Money Flow: | -1550349 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (158.53 - 164.47) | Buy |
| Bollinger Bands (100): | (154.29 - 163.63) | Buy |
RGC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.21 | Buy |
| Relative Strength Index (14 RSI): | 87.06 | Buy |
| Chaikin Money Flow: | 2558033 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.04 - 28.92) | Buy |
| Bollinger Bands (100): | (11.09 - 21.37) | Buy |
CBRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 163.85 | Buy |
| 20-day SMA: | 161.91 | Buy |
| 50-day SMA: | 158.06 | Buy |
| 200-day SMA: | 146.27 | Buy |
| 8-day EMA: | 164.19 | Buy |
| 20-day EMA: | 162.38 | Buy |
| 50-day EMA: | 158.31 | Buy |
| 200-day EMA: | 107.51 | Buy |
RGC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.75 | Buy |
| 20-day SMA: | 22.49 | Buy |
| 50-day SMA: | 17.26 | Buy |
| 200-day SMA: | 14.27 | Buy |
| 8-day EMA: | 31.19 | Buy |
| 20-day EMA: | 24.47 | Buy |
| 50-day EMA: | 19.59 | Buy |
| 200-day EMA: | 13.98 | Buy |
CBRE Group, Inc. Earnings Growth & CBRE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.74 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $1.16 per share.
Regencell Bioscience Holdings Ltd. Earnings Growth & RGC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CBRE Group, Inc. Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regencell Bioscience Holdings Ltd. Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||